Fat Grafting to the Breast: Same Procedure, Covered or Cosmetic

The short version

• Autologous fat grafting to the breast uses 15771 for the first 50 cc of injectate and 15772 for each additional 50 cc, coded by volume delivered.
• As part of post-mastectomy reconstruction, it is covered under the Women’s Health and Cancer Rights Act, which mandates coverage of reconstruction and symmetry.
• The diagnosis linkage proves it: Z42.1 for reconstruction after mastectomy, with Z90.1x and the cancer history Z85.3.
• The identical procedure done for cosmetic breast augmentation is not covered, so the diagnosis, not the technique, decides coverage.

Fat grafting to the breast is covered or cosmetic by diagnosis

Autologous fat grafting to the breast is the same operation whether it’s covered or not. What changes is the reason.

Harvest fat by liposuction, process it, inject it into the breast, the technique is identical for a post-mastectomy reconstruction patient and a cosmetic augmentation patient. But one is covered by federal law and the other isn’t a covered benefit at all. The entire coverage decision rides on the diagnosis linkage that establishes why the graft was done, which means the coding has to prove the context, not just the procedure.

This is the same covered-versus-cosmetic logic that runs through so much of plastic surgery billing, the kind we walk in breast reduction and the Schnur scale. With fat grafting, the deciding factor is whether a mastectomy sits in the history.

Coding fat grafting: 15771 and 15772 by the cc

Fat grafting got its own volume-based codes more recently than many practices realize.

In 2020, CPT deleted the old omnibus grafting code 20926 and split autologous fat grafting into anatomy- and volume-specific codes. For the breast, which sits in the trunk-and-breast family, the codes are 15771 for the first 50 cc of injectate and 15772 for each additional 50 cc, or part thereof. The finer 25 cc tier, 15773 and 15774, is for the face, eyelids, neck, hands, and feet, not the breast. Volume is measured by injectate delivered, and the add-on rounds up, so 120 cc to the breast is 15771 plus 15772 twice.

Document the total cc delivered in the operative note, because that number justifies the base code plus each add-on unit. Bill 15771 without recording the volume and the add-on units have nothing to stand on, which downcodes the claim.

On the dollars, the add-on is where breast cases live. Medicare pays 15771 about $663 and each 15772 roughly $206 — and because a breast reconstruction graft usually runs well past 50 cc, the add-on units carry most of the payment: 150 cc is 15771 plus two 15772s (about $1,075), 250 cc is 15771 plus four (about $1,487). That’s the concrete reason the cc count in the note isn’t optional. (When the fat is harvested by direct excision rather than liposuction, the graft is 15769 instead; the finer 25 cc face tier is 15773/15774.)

On units: the count tracks injectate volume, and each 15772 covers 50 cc “or part thereof,” so it rounds up. There’s no fixed CMS units-per-day cap on 15772 in the base edits, which means the add-on units simply follow the documented cc — but unusually high volume draws medical review and can start to read as cosmetic, so the op-note number is both your justification and your ceiling.

And fat grafting rarely happens alone in a reconstructed breast — it rides along with capsule and implant work, and almost none of it bundles. 15771/15772 carry no NCCI edit with capsulectomy or capsule revision (19370/19371), implant removal (19328), tissue expander or implant placement (19357/19340/19342), or revision of the reconstructed breast (19380). Billing 19380 with 15771/15772 is the common pairing, and it’s clean — revise the reconstructed breast and graft it for contour, both pay, with documentation. The one exception is reduction mammaplasty (19318), which bundles 15771 but is breakable with a modifier when the graft is a distinct service.

These are Medicare national averages at the 2026 conversion factor, and NCCI edits change quarterly; your locality and every commercial contract differ, so check your own payer grid and current edits.

The diagnosis linkage that makes it covered

The law that covers breast reconstruction is specific, and the claim has to speak its language.

The Women’s Health and Cancer Rights Act requires group health plans that cover mastectomy to also cover all stages of reconstruction, surgery on the other breast to produce symmetry, and treatment of complications. Fat grafting used within that reconstruction, as a stage, a revision, or a symmetry procedure, is covered. But the diagnosis linkage has to invoke it: Z42.1, encounter for breast reconstruction following mastectomy, as the reason for the visit, with Z90.1x for the acquired absence of the breast and Z85.3 for the personal history of breast cancer. Aetna’s breast reconstruction policy (CPB 0185) confirms the payer view that fat grafting is medically necessary within reconstruction.

Z42.1 first. That’s the code that tells the payer this is WHCRA-mandated reconstruction, not augmentation. The reciprocal is a costly omission: the same graft, billed without the post-mastectomy diagnosis linkage, reads as cosmetic and denies, because nothing on the claim connected it to the mastectomy.

Cosmetic augmentation is the same procedure, not covered

The honest half of this is that the identical operation, done for augmentation, is not a covered benefit.

WHCRA is triggered by mastectomy. Fat grafting for purely cosmetic breast enhancement, with no cancer history and no reconstruction context, falls outside it and outside coverage. Coding a cosmetic augmentation with a reconstruction diagnosis to force coverage isn’t aggressive coding; it’s a misrepresentation that invites recoupment and worse. When a patient wants cosmetic fat grafting, that’s a cosmetic agreement and a self-pay conversation, handled separately from any insurance claim.

The diagnosis has to be true, not convenient. The whole coverage argument for reconstruction fat grafting rests on the mastectomy being real and documented, which is exactly why it can’t be borrowed for a case that doesn’t have one.

What a breast fat-grafting claim needs before you bill 15771

Fat-grafting denials on legitimate reconstruction almost always trace to a claim that didn’t prove the reconstruction context or didn’t document the volume.

1. Code the volume. 15771 for the first 50 cc and 15772 for each additional 50 cc, with the total injectate documented in the note.
2. Establish the reconstruction linkage. Z42.1 as the encounter reason, with Z90.1x laterality and Z85.3 cancer history where applicable.
3. Use the breast family. 15771 and 15772, not the 25 cc face-and-extremity codes.
4. Keep cosmetic augmentation separate. Its own self-pay agreement, never a borrowed reconstruction diagnosis.

The procedure is the same on both sides of the line; the diagnosis and the documented volume are what make reconstruction covered and keep cosmetic honest. Getting that linkage right before submission is the kind of check our medical billing team runs so a WHCRA-covered graft isn’t denied as augmentation. (Documentation checklist for 15771, free: the Medical Necessity tool on Billing IQ.)

Frequently asked questions

This article explains how these codes tend to get paid — it is not coding, billing, or legal advice. Some of the codes here are bundled into the main procedure, or fall into grey areas that vary by payer. Before billing anything in a grey area, confirm it with your own coding and compliance team and the current guidance from the American Society of Plastic Surgeons (ASPS), Medicare (CMS), and AMA CPT. When in doubt, don’t bill it.